These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Application of CRISPR/Cas9 genome editing to the study and treatment of disease. Pellagatti A; Dolatshad H; Valletta S; Boultwood J Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103 [TBL] [Abstract][Full Text] [Related]
15. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease. Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583 [TBL] [Abstract][Full Text] [Related]
16. Application of gene-editing technologies to HIV-1. Drake MJ; Bates P Curr Opin HIV AIDS; 2015 Mar; 10(2):123-7. PubMed ID: 25612322 [TBL] [Abstract][Full Text] [Related]
17. Ethical and Societal Questions Loom Large as Gene Editing Moves Closer to the Clinic. Hampton T JAMA; 2016 Feb; 315(6):546-8. PubMed ID: 26810772 [No Abstract] [Full Text] [Related]
18. [Results of comprehensive management of patients with chronic lower limb ischaemia using gene-engineering technologies of angiogenesis stimulation (Part 2)]. Gavrilenko AV; Voronov DA Angiol Sosud Khir; 2015; 21(4):29-35. PubMed ID: 26673292 [TBL] [Abstract][Full Text] [Related]
19. Harnessing the Power of Genetic Engineering for Patients With Mitochondrial Eye Diseases. Yu-Wai-Man P J Neuroophthalmol; 2017 Mar; 37(1):56-64. PubMed ID: 28187082 [No Abstract] [Full Text] [Related]